6:08 PM
 | 
Nov 02, 2012
 |  BC Extra  |  Politics & Policy

CMS to price molecular pathology tests as lab services

CMS is revising the way it reimburses molecular pathology tests, but it remains unclear whether suppliers will get more or less money from the agency. Beginning next year, CMS will determine the reimbursement rate for molecular pathology...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >